According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$26.3 M. In 2022 the company made an earning of -$37.44 M a decrease over its 2021 earnings that were of -$35.85 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$26.3 M | -29.76% |
2022 | -$37.44 M | 4.43% |
2021 | -$35.85 M | -24.56% |
2020 | -$47.52 M | 4.74% |
2019 | -$45.37 M | 65.13% |
2018 | -$27.48 M | 155.07% |
2017 | -$10.78 M | 13.93% |
2016 | -$9.46 M | 31.18% |
2015 | -$7.21 M | -72.5% |
2014 | -$26.21 M | 356.62% |
2013 | -$5.74 M | -60.55% |
2012 | -$14.55 M | 218.41% |
2011 | -$4.57 M | 0.74% |
2010 | -$4.54 M | -32.54% |
2009 | -$6.73 M | -66.98% |
2008 | -$20.36 M | -14.22% |
2007 | -$23.74 M | 7.04% |
2006 | -$22.18 M | 27.95% |
2005 | -$17.33 M | 4.51% |
2004 | -$16.58 M | -15.84% |
2003 | -$19.7 M | -55.29% |
2002 | -$44.07 M | -34.05% |
2001 | -$66.82 M |